NOT-AI-02-013: PARTNERSHIPS FOR NOVEL THERAPEUTIC, DIAGNOSTIC AND VECTOR CONTROL STRATEGIES IN INFECTIOUS DISEASES

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®

PARTNERSHIPS FOR NOVEL THERAPEUTIC, DIAGNOSTIC AND VECTOR CONTROL STRATEGIES 
IN INFECTIOUS DISEASES   ADDENDUM TO PAR-02-026

Release Date:  April 10, 2002

NOTICE:  NOT-AI-02-013 (also see PAR-02-026, NOT-AI-02-22, NOT-AI-02-007)

National Institute of Allergy and Infectious Diseases (NIAID)
 (http://www.niaid.nih.gov/default.htm)

Letter of Intent Receipt Date:  May 20, 2002
Application Receipt Date:  June 20, 2002

The National Institute of Allergy and Infectious Diseases is removing 
language as well as stating the letter of intent receipt date previously 
omitted.  The NIAID would also like to announce that additional initiatives 
relating to the areas of Bio-Defense and Influenza will soon be published in 
the "NIH Guide".  

The Letter of Intent receipt date for the second receipt date is May 20, 
2002.  The Application receipt date had been changed to June 20, 2002, as 
announced in NOT-AI-02-007 at http://grants.nih.gov/grants/guide/notice-
files/NOT-AI-02-007.html

Under Research Objectives and Scope, area #4 will be removed and addressed in 
upcoming initiatives:

#4. Development of Vaccines for Selected Agents of Bioterrorism:

Responsive applications to scientific area "4." include those that propose to 
develop vaccines to prevent infection and/or disease from CDC Category A 
agents of bioterrorism (B. anthracis, Clostridium botulinum. Yersinia pestis, 
Variola major, Francisella tularensis and causative pathogens of viral 
hemorrhagic fevers).  Proposed research may fall anywhere along a broad 
spectrum of activities from candidate identification and validation through 
preclinical development and early human testing (Phase I and II trials).

Also note that applications relating to Influenza will also not be accepted 
under this PAR.  An announcement coming out in the next few months will apply 
to both the above areas.

Complete information about the grant program, PAR-02-026, may be obtained at 
http://www.niaid.nih.gov/ncn/pa/PAR-02-026.html.

INQUIRIES

Written and telephone inquiries are encouraged.  The opportunity to clarify 
any issues or questions from potential applicants is welcome.

Direct inquiries regarding programmatic, research scope, and eligibility 
issues to:  

Ann M. Ginsberg, M.D., Ph.D.  
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases  
Room 3133, MSC-7630
6700-B Rockledge Drive
Bethesda, MD  20892-7630
Telephone:  (301) 496-5305
FAX:  (301) 496-8030
E-Mail:  [email protected]
  
Direct inquiries regarding fiscal matters to:  

Ms. Jeanette Gordon                
Division of Extramural Activities  
National Institute of Allergy and Infectious Diseases  
Room 3222, MSC-7614
6700-B Rockledge Drive  
Bethesda, MD  20892-7614
Telephone:  (301) 402-5065
Fax:  (301) 480-3780
E-mail:  [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices